Bone disorder
Therapeutic area
Rheumatology
Rare disease
No
- Definition
- Diseases of bones.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Bone disorder
- Therapeutic area
- Rheumatology
- bone disorder
- bone element disease
- bone element disease or disorder
- disease of bone element
- disease or disorder of bone element
- disorder of bone element
- All therapeutic areas
- Rheumatology
- Severity
- Unknown
- MONDO ID
- MONDO:0005381
- Parent condition
- MONDO:0005172
Related records
Broader conditions (5)
- Disease
- Disease by body system or component
- Human disease
- Musculoskeletal system disorder
- Skeletal system disorder
Narrower conditions (1,732)
- 2q37 microdeletion syndrome
- 3M syndrome 1
- 3M syndrome 2
- 3M syndrome 3
- Abnormal mineralization disorder
- Absence deformity of leg-cataract syndrome
- Absent radius-anogenital anomalies syndrome
- Absent tibia-polydactyly-arachnoid cyst syndrome
- ACAN-related short stature spectrum
- Acheiria
- Acheiria, bilateral
- Acheiria, unilateral
- Acheiropody
- Achondrogenesis
- Achondrogenesis type IA
- Achondrogenesis type IB
- Achondrogenesis type II
- Achondroplasia
- Acquired polycythemia vera
- Acrocallosal syndrome
Trials (1,041)
- "Bio-logical" Carbon Fiber Intramedullary Nail Biomechanical Test and Preliminary Clinical Results
- 12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)
- 12-month Study of AMG 073 in Renal Osteodystrophy
- 18F-sodium Fluoride (NaF) PET to Replace Bone Scintigraphy: Safety and Efficacy Assessment
- 3D Analysis of Cemento-Osseous Lesions
- 3D Imaging of the Hip Using DXA
- 3D-Printed Personalized Metal Implant in Surgical Treatment of Ankle Bone Defects
- 6 Years Study on Changes in Bone Quality, Bone Turnover and Curve Severity in AIS With and Without Calcium and Vit-D Supplementation
- 855303-RNA Biomarker Validation
- A Clinical Investigation of the M2a-Magnum™ Hip System
- A Clinical Study Evaluating the Safety and Efficacy of the VCFix Spinal System for Treatment of Vertebral Compression Fractures
- A Clinical Trial to Evaluate Safety of Vosoritide in At-risk Infants With Achondroplasia
- A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia
- A Comparative Study Between Intrathecal Dexmedetomidine VS Ketamine With Intrathecal Bupivacaine in Orthopedic Lower Limb Surgeries.
- A Comparison of Casting and Splinting in Pediatric Radial Buckle Fractures
- A Comparison of Serum and Urine N-telopeptide Marker
- A Comparison of Stainless Steel and Bioabsorbable Screw Fixation of Lisfranc Foot Injuries
- A Comparison of Steel and Bioabsorbable Screw Fixation of Lisfranc Foot Injuries
- A Culinary Intervention for Bone Health
- A Different Approach to Preventing Thrombosis
Approved drugs (13)
- Alendronic acid
- Burosumab
- Denosumab
- Dibotermin alfa
- Eptotermin alfa
- Etidronic acid
- Pamidronic acid
- Risedronic acid
- Romosozumab
- Strontium ranelate
- Tiludronic acid
- Vosoritide
- Zoledronic acid
Drugs in development (10)
- Bafetinib Phase 2
- Clodronic acid Phase 3
- Estrogens, conjugated Phase 3
- Ibandronic acid Phase 3
- Ipriflavone Phase 2
- Mecasermin Phase 2
- Medroxyprogesterone acetate Phase 3
- Menatetrenone Phase 3
- Progesterone Phase 3
- Zoledronic acid anhydrous Phase 3
Other linked drugs (4)
- Eliglustat tartrate
- Neridronic acid
- Technetium TC 99M medronate
- Velaglucerase alfa